Processa Pharmaceuticals, Inc. Common PCSA
$2.43
-2.80%
at last close
Recent SEC Filings
| Form | Description | Filed | Document |
|---|---|---|---|
| 10-Q | 10-Q | 2026-08-14 | View → |
| 4 | FORM 4 | 2026-08-11 | View → |
| 8-K | 8-K | 2026-08-04 | View → |
| 4 | Insider transaction | 2026-07-30 | View → |
| 8-K | 8-K | 2026-07-29 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-28 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-07-01 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| 4 | FORM 4 | 2026-06-30 | View → |
| DEF 14A | DEF 14A | 2026-06-18 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-16 | View → |
| 4 | FORM 4 | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-06-01 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 4 | FORM 4 | 2026-05-19 | View → |
| 10-Q | 10-Q | 2026-05-07 | View → |
| 4 | FORM 4 | 2026-05-01 | View → |
Filings are sourced directly from the SEC's EDGAR system. Annual reports (10-K) and quarterly reports (10-Q) carry the full financial statements; 8-K filings disclose material events between reports; Form 4 filings record insider purchases and sales.
Key Stats
- Last Close
- $2.43
- Market Cap
- $8.15 million
- 52-Week Range
- $1.67 – $14.24
- Average Volume
- 451K shs
Data is delayed and provided for informational purposes only. Not investment advice. See our disclaimer.